ENLV Competitors & Alternatives
Compare Enlivex Therapeutics Ltd with similar stocks in the same industry
Biotechnology
ENLV
Main Stock$0.72
Tradestie Score
58
Market Cap
$25.02M
P/E Ratio
0.0
Analyst Upside
+2687.5%
Top Competitors
227 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
KYTX
Kyverna Therapeutics, Inc. Common Stock
|
$8.67
|
$258.18M | - | 52 | Compare |
|
VTYX
Ventyx Biosciences, Inc. Common Stock
|
$14.00
|
$256.71M | - | 53 | Compare |
|
CABA
Cabaletta Bio, Inc. Common Stock
|
$3.65
|
$211.28M | - | 57 | Compare |
|
SLS
SELLAS Life Sciences Group, Inc. Common Stock
|
$7.78
|
$211.22M | - | 60 | Compare |
|
ACRS
Aclaris Therapeutics, Inc.
|
$4.52
|
$202.58M | - | 55 | Compare |
|
CBIO
Crescent Biopharma, Inc. Common Stock
|
$20.74
|
$199.71M | - | 50 | Compare |
|
AVTX
Avalo Therapeutics, Inc. Common Stock
|
$16.35
|
$170.45M | - | 52 | Compare |
|
CLYM
Climb Bio, Inc. Common Stock
|
$11.00
|
$133.50M | - | 50 | Compare |
|
ANRO
Alto Neuroscience Inc.
|
$21.22
|
$110.20M | - | 55 | Compare |
|
ENTX
Entera Bio Ltd. Ordinary Shares
|
$1.24
|
$84.52M | - | 61 | Compare |
More ENLV Analysis
Data updated: May 24, 2026 | Industry: Biotechnology (SIC 2834)
227 stocks in this industry